Now we are looking in to one more pharma stock is now available very attractive price for long term portfolio.
"JAGSONPAL PHARMACEUTICALS LTD"
Founded in 1964 the company specializes in developing and
manufacturing bulk drugs and pharmaceutical formulations. Over the past 52 years the firm has grown by leaps and bounds. The firm is committed
to sustainable growth and is aggressively pursuing growth through market
penetration, market expansion and multi-national expansion.
Jagsonpal is ranked 68th in the Indian pharmaceutical
industry. The industry is comprised of over 28,000 manufacturing units
putting Jagsonpal in the ivy league of the Indian Pharmaceutical
companies. The firm’s objective is to increase market share and become a
dominant player in the Indian Pharmaceutical Industry.
Jagsonpal has an expanding international portfolio of
affiliates, joint ventures and representative offices across the globe
making it a truly international operation. The firm is represented by
2,500 agents worldwide and has offices in 3 continents. The company’s
operations span Russia, Brazil, USA, Ukraine, Sri Lanka, Cameroon,
Thailand, Argentina, Germany, Switzerland, Korea, Egypt and Vietnam
making Jagsonpal's reach truly global.
In 1978, Fourteen years later, the company had outgrown the startup phase and was incorporated as a private limited company. Jagsonpal was now a fast growing pharmaceutical company. The firm was committed to healing India with quality pharmaceutical products and had its eyes firmly set on becoming one of the country’s leading pharmaceutical companies.
In 1986 Jagsonpal went public on the BSE with an issue of
17.76 lakh (One hundred thousand) shares. This was the first time the
firm had tapped the capital markets. Jagsonpal had come a long way from
its birth as a chemists shop in Delhi. After this there was no looking
back and Jagsonpal had its eyes set firmly on the future.
The firm is already a multi-national player with a presence in over 15 countries. Jagsonpal reaps substantial benefits by being a global player. The firm sells its existing products in new international markets. The firm is able to share research and development costs with foreign companies by licensing its own products to them. Jagsonpal has also obtained licenses from foreign companies to sell their products in India.
Jagsonpal’s operations span Russia, Brazil, USA, Ukraine,
Sri Lanka, Cameroon, Thailand, Argentina, Germany, Switzerland, Korea,
Egypt and Vietnam making Jagsonpal's reach truly global.
The Company has an expanding international portfolio of
affiliates, joint ventures and representative offices across the globe. A
of Jagsonpal’s strategy is to grow through international expansion.
The firm welcomes strategic alliances with foreign
companies that foster technology sharing, joint research and
development, entry into new markets or new product development.
The following are Jagsonpal’s top selling brands: